Drugs / BICX104
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07269873 | Mar → Dec 2026 expected | — | BioCorRx Pharmaceuticals Inc | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BICX104 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07269873 ↗ |
| Known as | naltrexone | “BICX104 naltrexone implantable pellet” NCT07269873 ↗ |
| Route | Subcutaneous | “subcutaneous implantable pellet” NCT07269873 ↗ |